Institution
Tianjin Medical University Cancer Institute and Hospital
Also known as: 天津医科大学肿瘤医院 · TMUCIH
- 304running trials
- 77closed trials
- 3researchers
- 16,772publications (OpenAlex)
Researchers
Running trials
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruiting
Low-Dose Radiotherapy Plus Adebrelimab and Chemotherapy for Extensive-Stage Small Cell Lung Cancer
Not yet recruiting
Recruiting
Recruiting
Hydrogel Spacer During Definitive Radiotherapy for Cervical Cancer
Not yet recruiting
Fecal Microbiota Transplantation Combined With QL1706 Plus Bevacizumab for Advanced HCC
Recruiting
Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
Not yet recruiting
Albumin-bound Paclitaxel (Ⅱ)-Combined Regimens for Pancreatic Cancer
Not yet recruiting
Recruiting
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma
Recruiting
Recruiting
Recruiting
Phase II Study of SHR-A1811 for Ultra-Low HER2 Advanced Breast Cancer
Not yet recruiting
Standardized MRI and Structured Reporting for Esophageal Squamous Cell Carcinoma
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Five-Element Music Therapy for Psychological Distress in Pancreatic Cancer Chemotherapy
Not yet recruiting
Baduanjin for Quality of Life in Pancreatic Cancer Chemotherapy
Recruiting
SKB500 Combinations in Patients With Esophageal Squamous Cell Carcinoma
Not yet recruiting
Recruiting
Comparing ICI Followed By CCRT And CCRT Followed By Immunotherapy In Unresectable LA-ESCC
Recruiting
Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors
Not yet recruiting
Not yet recruiting
Phase II Trial of SFRT Plus Chemo-immunotherapy for LA-NSCLC With Suboptimal Neoadjuvant Response
Recruiting
Not yet recruiting
Not yet recruiting
Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer
Recruiting
Active, not recruiting
Eparlitozoviril as Adjuvant Therapy for Resectable HCC With MVI
Active, not recruiting
Induction Chemoimmunotherapy Followed by Deescalated Definitive Radiotherapy in Head and Neck Cancer
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence
Recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Not yet recruiting
A Preliminary Efficacy of SNA028 in Patients With Advanced Colorectal Cancer Positive for GPA33
Recruiting
Recruiting
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
Active, not recruiting
Sintilimab Combined With Ipilimumab (N01) Plus AG as First-line Therapy for uBTC.
Recruiting
Recruiting
Recruiting
Showing 50 of 304.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer59 recruiting
- Gastric and oesophageal cancer29 recruiting
- Colorectal cancer21 recruiting
- Liver and biliary tract cancer17 recruiting
- Pancreatic cancer15 recruiting
- Metastatic breast cancer13 recruiting
- Head and neck cancer9 recruiting
- Endometrial cancer7 recruiting
- Cervical cancer6 recruiting
- Childhood cancers6 recruiting
- Kidney cancer5 recruiting
- Melanoma5 recruiting
- Multiple myeloma5 recruiting
- Ovarian cancer5 recruiting
- Triple-negative breast cancer5 recruiting
- Brain metastases4 recruiting
- Prostate cancer4 recruiting
- Bladder cancer3 recruiting
- Neuroblastoma3 recruiting
- Neuroendocrine tumours3 recruiting
- Sarcoma3 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Thyroid cancer2 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gastroparesis1 recruiting
- Insomnia1 recruiting
- Mantle cell lymphoma1 recruiting
- Neurofibromatosis type 11 recruiting
- Thymoma and thymic carcinoma1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer
Completed
Terminated
Terminated
TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Concentrated Complex Plant Dietary Elements for Chemotherapy-Induced Diarrhea
Completed
Study of B013 and Nab-Paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
Completed
Completed
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
Completed
Completed
Completed
Completed
Effect of Neoadjuvant Anti-PD-1 Immunotherapy on Perioperative Analgesia and Postoperative Delirium
Completed
Completed
Terminated
Completed
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
Terminated
Completed
Completed
Completed
Completed
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer
Completed
Terminated
Terminated
Completed
Recruiting
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Completed
Completed
Terminated
Completed
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Completed
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Completed
Terminated
A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC.
Completed
Completed
Completed
Completed
Showing 50 of 77.
Registry name variants (41)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Tianjin Medical University Cancer Institute & Hospital
Tianjin, 300000
174 trials
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality 300060
163 trials
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Tianjin, 300060
2 trials
Contact: Hongjing Jiang
Contact: Hongjing Jiang, MD,PhD
Tianjin Medical University Cancer Institute and Hospital (Site 1161)
Tianjin, Tianjin Municipality 300060
2 trials
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin 300000
Tianjin, Tianjin Municipality 300060
2 trials
Contact: Xudong Wang
Contact: Xudong Wang
Tianjin Medical University Cancer Institute & Hospital (Site 0111)
Tianjin, Tianjin Municipality 300060
2 trials
Tianjin Medical University Cancer Institute & Hospital (Site 0155)
Tianjin, Tianjin Municipality 300060
2 trials
Department of Hepatobiliary Oncology and Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer
Tianjin, 300060
1 trial
NCT06766643Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Contact: Song Tianqiang T Song, MD
Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China
Tianjin, Tianjin Municipality 300060
1 trial
NCT07726446Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors
Contact: Tianqiang T Song, MD
Tianjin Cancer Hospital (Tianjin Medical University Cancer institute & Hospital) (Site 0706)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin medical university cancer hospital and institute
Tianjin, Tianjin Municipality 300060
1 trial
Contact: Tianjin medical university cancer hospital and institute
Tianjin Medical University Cancer Institute and Hopital
Tianjin, Tianjin Municipality 300000
1 trial
NCT03358602Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
Contact: Dong Xu Wang, Ph.D
Tianjin Medical University Cancer Institute and Hospital
Hexi District, Tianjin, 300060
1 trial
Tianjin Medical University Cancer Institute and Hospital - 3208
Tianjin, Tianjin Municipality
1 trial
Tianjin Medical University Cancer Institute and Hospital(Lead Center)
Tianjin
1 trial
Contact: Dongsheng Yue Chief Physician of Surgery
Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Huan-Hu-Xi
Tianjin, Tianjin Municipality 300381
1 trial
Tianjin Medical University Cancer Institute and Hospital (Site 0003)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute and Hospital (Site 0422)
Tianjin, Tianjin Municipality 300000
1 trial
Tianjin Medical University Cancer Institute and Hospital (Site 0720)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute and Hospital (Site 6029)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China 300060
Tianjin, Tianjin Municipality
1 trial
Contact: Dingzhi Huang
Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin 300060
Tianjin, Tianjin Municipality 300381
1 trial
Tianjin Medical University Cancer Institute & Hospital (0606)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital - Breast Tumor Department
Tianjin, Tianjin Municipality 300060
1 trial
Contact: Nadene Zack, MS
Tianjin Medical University Cancer Institute & Hospital, Hepatobiliary Oncology Department
Tianjin, West Lake District 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer
Tianjin, 300060
1 trial
Tianjin Medical University - Cancer Institute & Hospital - Oncology
Tianjin, Tianjin Municipality
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 0392)
Tianjin, Tianjin Municipality 300060
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
Tianjin Medical University Cancer Institute & Hospital (Site 0505)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 0606)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 0804)
Tianjin, Tianjin Municipality 300000
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 2447)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 3103)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 3204)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 4054)
Tianjin, Tianjin Municipality 300000
1 trial
Tianjin Medical University Cancer Institute & Hospital (Site 8035)
Tianjin, Tianjin Municipality 300060
1 trial
Tianjin Medical University Cancer Institute & Hospital (TMUCIH)
Tianjin, Tianjin Municipality 300060
1 trial
NCT07481903Effect of Acupuncture on Psychoneurological Symptom Cluster in Breast Cancer Survivors
Contact: Bin Wang, PhD
Tianjin medical university Cancer Institut & Hospital
Tianjin, Tianjin Municipality 300000
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Lung cancer205 works · 102 trials
- Liver and biliary tract cancer80 works · 37 trials
- Gastric and oesophageal cancer73 works · 51 trials
- Pancreatic cancer55 works · 19 trials
- Triple-negative breast cancer41 works · 9 trials
- Ovarian cancer34 works · 16 trials
- Kidney cancer27 works · 10 trials
- Metastatic breast cancer27 works · 26 trials
- Diffuse large B-cell lymphoma25 works · 6 trials
- Thyroid cancer24 works · 4 trials
- Cervical cancer23 works · 7 trials
- Brain metastases22 works · 5 trials
- Neuroblastoma19 works · 3 trials
- Follicular lymphoma8 works · 3 trials
- Hepatitis B6 works · 0 trials
- Thymoma and thymic carcinoma3 works · 1 trial
Institution data: ROR 0152hn881 (CC0-1.0)Updated 15 Nov 2026